Finnegan partner Ningling Wang will present “Innovation & IP Issues in Antibody Drugs’ R&D” at BIT Congress’ ninth annual International Congress of Antibodies. The program will take place at the Wanda Realm hotel in Beijing, China. For more information, or to register, please see BIT Congress’ website.
